Novartis AG (NYSE:NVS) Given Price Target Of $92.75


As per Novartis AG (NYSE:NVS)’s news release on 2016-04-11, its shareholders will get cash dividend of $2.30275 per share. The recent press release updated on the record date and payout date, which stands at 2016-02-26 and 2016-04-15, respectively.

The stock of Novartis AG (NYSE:NVS) will commence trading ex-dividend from 2016-02-24, until which the shareholders are compelled to keep the holdings so as to qualify for the dividend. Evaluating the dividend distribution mode, it was noted that last year Novartis AG (NYSE:NVS) disbursed $2.303 in dividend compared to distribution of $1.794, a year ago. It highlights a sharp difference in cash payouts of the two years. This shows a major deviation of 25.9045%.

The past track record of five years substantiates that the average payout of Novartis AG (NYSE:NVS) stands at $2.044, implying 6.4467% growth. The company recorded earnings of $1.26 a share in the preceding fiscal.

The interim price target for Novartis AG (NYSE:NVS) is set at $92.75. This level is the mean price reached by averaging the stock views of 4 analysts. All these are top brokerages of Wall Street and trail the company’s performance regularly. The best price estimate is seen at $115 and the lowest level is established at 81. This broad range highlights a standard deviation of $15.195 in reported estimates.

AlphaOne has allotted A sentiment score of 0.295 to Novartis AG (NYSE:NVS) while impact score assigned is 67 as on as on 2016-07-17.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 26 times, 1 visits today)